<?xml version="1.0" encoding="UTF-8"?>
<ref id="B27-viruses-09-00147">
 <label>27.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Tollefson</surname>
    <given-names>A.E.</given-names>
   </name>
   <name>
    <surname>Spencer</surname>
    <given-names>J.F.</given-names>
   </name>
   <name>
    <surname>Ying</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Buller</surname>
    <given-names>R.M.</given-names>
   </name>
   <name>
    <surname>Wold</surname>
    <given-names>W.S.</given-names>
   </name>
   <name>
    <surname>Toth</surname>
    <given-names>K.</given-names>
   </name>
  </person-group>
  <article-title>Cidofovir and brincidofovir reduce the pathology caused by systemic infection with human type 5 adenovirus in immunosuppressed syrian hamsters, while ribavirin is largely ineffective in this model</article-title>
  <source>Antivir. Res.</source>
  <year>2014</year>
  <volume>112</volume>
  <fpage>38</fpage>
  <lpage>46</lpage>
  <pub-id pub-id-type="doi">10.1016/j.antiviral.2014.10.005</pub-id>
  <?supplied-pmid 25453340?>
  <pub-id pub-id-type="pmid">25453340</pub-id>
 </element-citation>
</ref>
